111 related articles for article (PubMed ID: 9118034)
1. Lung carcinoma patients with a family history of cancer and lymphocyte primary chromosome 9 aberrations.
Wu X; Dave BJ; Jiang H; Pathak S; Spitz MR
Cancer; 1997 Apr; 79(8):1527-32. PubMed ID: 9118034
[TBL] [Abstract][Full Text] [Related]
2. A case-control analysis of lymphocytic chromosome 9 aberrations in lung cancer.
Zhu Y; Spitz MR; Strom S; Tomlinson GE; Amos CI; Minna JD; Wu X
Int J Cancer; 2002 Dec; 102(5):536-40. PubMed ID: 12432559
[TBL] [Abstract][Full Text] [Related]
3. Lung cancer, smoking patterns, and mutagen sensitivity in Mexican-Americans.
Strom SS; Wu S; Sigurdson AJ; Hsu TC; Fueger JJ; Lopez J; Tee PG; Spitz MR
J Natl Cancer Inst Monogr; 1995; (18):29-33. PubMed ID: 8562219
[TBL] [Abstract][Full Text] [Related]
4. D2 dopamine receptor gene polymorphisms among African-Americans and Mexican-Americans: a lung cancer case-control study.
Wu X; Hudmon KS; Detry MA; Chamberlain RM; Spitz MR
Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1021-6. PubMed ID: 11045783
[TBL] [Abstract][Full Text] [Related]
5. Deletion in poly(ADP-ribose)polymerase pseudogene and lung cancer risk.
Wu X; Hsu TC; Cao S; Lee JJ; Amos CI; Spitz MR
Carcinogenesis; 1998 Jan; 19(1):93-8. PubMed ID: 9472699
[TBL] [Abstract][Full Text] [Related]
6. Specific chromosome aberrations in peripheral blood lymphocytes are associated with risk of bladder cancer.
Shao L; Lerner SL; Bondaruk J; Czerniak BA; Zeng X; Grossman HB; Spitz MR; Wu X
Genes Chromosomes Cancer; 2004 Dec; 41(4):379-89. PubMed ID: 15390184
[TBL] [Abstract][Full Text] [Related]
7. A case-control study of nonrandom distribution of bleomycin-induced chromatid breaks in lymphocytes of lung cancer cases.
Wu X; Hsu TC; Annegers JF; Amos CI; Fueger JJ; Spitz MR
Cancer Res; 1995 Feb; 55(3):557-61. PubMed ID: 7530597
[TBL] [Abstract][Full Text] [Related]
8. Fluorescent in situ hybridization analysis in blood lymphocytes of lung cancer patients.
Dave BJ; Risin SA; Spitz MR; Pathak S
Anticancer Res; 1996; 16(3A):1187-92. PubMed ID: 8702234
[TBL] [Abstract][Full Text] [Related]
9. Genetic susceptibility to lung cancer as determined by lymphocytic chromosome analysis.
Dave BJ; Hopwood VL; King TM; Jiang H; Spitz MR; Pathak S
Cancer Epidemiol Biomarkers Prev; 1995; 4(7):743-9. PubMed ID: 8672991
[TBL] [Abstract][Full Text] [Related]
10. Chromosome 5 aberrations and genetic predisposition to lung cancer.
Wu X; Zhao Y; Kemp BL; Amos CI; Siciliano MJ; Spitz MR
Int J Cancer; 1998 Oct; 79(5):490-3. PubMed ID: 9761118
[TBL] [Abstract][Full Text] [Related]
11. Genetic instability of specific chromosomes associated with a family history of cancer.
Zhu Y; Spitz MR; Hsu TC; Wu X
Cancer Genet Cytogenet; 2002 Jul; 136(1):73-7. PubMed ID: 12165456
[TBL] [Abstract][Full Text] [Related]
12. Benzo[a]pyrene diol epoxide-induced 9p21 aberrations associated with genetic predisposition to bladder cancer.
Hazra A; Grossman HB; Zhu Y; Luo S; Spitz MR; Wu X
Genes Chromosomes Cancer; 2004 Dec; 41(4):330-8. PubMed ID: 15390186
[TBL] [Abstract][Full Text] [Related]
13. Ethnic differences in poly(ADP-ribose) polymerase pseudogene genotype distribution and association with lung cancer risk.
Gu J; Spitz MR; Yang F; Wu X
Carcinogenesis; 1999 Aug; 20(8):1465-9. PubMed ID: 10426793
[TBL] [Abstract][Full Text] [Related]
14. Increased risk of lung cancer in individuals with a family history of the disease: a pooled analysis from the International Lung Cancer Consortium.
Coté ML; Liu M; Bonassi S; Neri M; Schwartz AG; Christiani DC; Spitz MR; Muscat JE; Rennert G; Aben KK; Andrew AS; Bencko V; Bickeböller H; Boffetta P; Brennan P; Brenner H; Duell EJ; Fabianova E; Field JK; Foretova L; Friis S; Harris CC; Holcatova I; Hong YC; Isla D; Janout V; Kiemeney LA; Kiyohara C; Lan Q; Lazarus P; Lissowska J; Le Marchand L; Mates D; Matsuo K; Mayordomo JI; McLaughlin JR; Morgenstern H; Müeller H; Orlow I; Park BJ; Pinchev M; Raji OY; Rennert HS; Rudnai P; Seow A; Stucker I; Szeszenia-Dabrowska N; Dawn Teare M; Tjønnelan A; Ugolini D; van der Heijden HF; Wichmann E; Wiencke JK; Woll PJ; Yang P; Zaridze D; Zhang ZF; Etzel CJ; Hung RJ
Eur J Cancer; 2012 Sep; 48(13):1957-68. PubMed ID: 22436981
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility to lung cancer in light smokers associated with CYP1A1 polymorphisms in Mexican- and African-Americans.
Ishibe N; Wiencke JK; Zuo ZF; McMillan A; Spitz M; Kelsey KT
Cancer Epidemiol Biomarkers Prev; 1997 Dec; 6(12):1075-80. PubMed ID: 9419406
[TBL] [Abstract][Full Text] [Related]
16. Lung cancer in Mexican-Americans and African-Americans is associated with the wild-type genotype of the NAD(P)H: quinone oxidoreductase polymorphism.
Wiencke JK; Spitz MR; McMillan A; Kelsey KT
Cancer Epidemiol Biomarkers Prev; 1997 Feb; 6(2):87-92. PubMed ID: 9037558
[TBL] [Abstract][Full Text] [Related]
17. Benzo(a)pyrene diol epoxide-induced chromosomal aberrations and risk of lung cancer.
Wei Q; Gu J; Cheng L; Bondy ML; Jiang H; Hong WK; Spitz MR
Cancer Res; 1996 Sep; 56(17):3975-9. PubMed ID: 8752166
[TBL] [Abstract][Full Text] [Related]
18. Chromosome aberrations in peripheral blood lymphocytes of lung cancer patients exposed to radon and air pollution.
Minina VI; Sinitsky MY; Druzhinin VG; Fucic A; Bakanova ML; Ryzhkova AV; Savchenko YA; Timofeeva AA; Titov RA; Voronina EN; Volobaev VP; Titov VA
Eur J Cancer Prev; 2018 Jan; 27(1):6-12. PubMed ID: 27232209
[TBL] [Abstract][Full Text] [Related]
19. Benzo(a)pyrene diol epoxide-induced chromosome 9p21 aberrations are associated with increased risk of bladder cancer.
Gu J; Horikawa Y; Chen M; Dinney CP; Wu X
Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2445-50. PubMed ID: 18768515
[TBL] [Abstract][Full Text] [Related]
20. Risk of lung cancer among white and black relatives of individuals with early-onset lung cancer.
Coté ML; Kardia SL; Wenzlaff AS; Ruckdeschel JC; Schwartz AG
JAMA; 2005 Jun; 293(24):3036-42. PubMed ID: 15972566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
